• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

La Jolla Pharmaceutical Company - Common Stock (NQ:LJPC)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 19, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about La Jolla Pharmaceutical Company - Common Stock

Innoviva Completes Acquisition of La Jolla Pharmaceutical
August 22, 2022
From Innoviva, Inc.
Via Business Wire
LJPC Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of La Jolla Pharmaceutical Company Is Fair to Shareholders
July 28, 2022
From Halper Sadeh LLP
Via Business Wire
LA JOLLA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of La Jolla Pharmaceutical Company - LJPC
July 11, 2022
From Kahn Swick & Foti, LLC
Via Business Wire
LJPC Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of La Jolla Pharmaceutical Company Is Fair to Shareholders
July 11, 2022
From Halper Sadeh LLP
Via Business Wire
Innoviva to Acquire La Jolla Pharmaceutical Company
July 11, 2022
From La Jolla Pharmaceutical Company
Via Business Wire
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Corporate Progress
May 16, 2022
From La Jolla Pharmaceutical Company
Via Business Wire
La Jolla Pharmaceutical Company Announces Share Repurchase Plan
November 17, 2021
From La Jolla Pharmaceutical Company
Via Business Wire
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2021 and Highlights Corporate Progress
November 04, 2021
From La Jolla Pharmaceutical Company
Via Business Wire
Tony Hodges, M.D., FACP, FCCP, Appointed Chief Medical Officer of La Jolla Pharmaceutical Company
September 10, 2021
From La Jolla Pharmaceutical Company
Via Business Wire
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2021 and Highlights Corporate Progress
August 05, 2021
From La Jolla Pharmaceutical Company
Via Business Wire
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2021 and Highlights Corporate Progress
May 07, 2021
From La Jolla Pharmaceutical Company
Via Business Wire
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap